neomycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
antibiotics, produced by Streptomyces strains	4247	1405-10-3

Description:

Molecule	Description
Synonyms: neomycin sulfate neomycin bykomycin endomixin fradiomycin sulfate mycerin sulfate neomycin sulphate neomycin palmitate	Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Molecular weight: 1551.66 Formula: C58H118N16O32 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

neomycin sulfate
neomycin
bykomycin
endomixin
fradiomycin sulfate
mycerin sulfate
neomycin sulphate
neomycin palmitate

Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.

Molecular weight: 1551.66
Formula: C58H118N16O32
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
5	g	O
1	g	P

ADMET properties:

Property	Value	Reference
BA (Bioavailability)	3 %	Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

Date	Agency	Company	Orphan
March 26, 1957	FDA	MONARCH PHARMS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Drug hypersensitivity	383.94	16.47	373	11461	310314	63166874
Macular degeneration	258.42	16.47	114	11720	24262	63452926
Toxic anterior segment syndrome	96.70	16.47	28	11806	1743	63475445
Type 2 diabetes mellitus	86.43	16.47	81	11753	63787	63413401
C-reactive protein	79.33	16.47	31	11803	4851	63472337
Swollen joint count increased	61.21	16.47	52	11782	36002	63441186
Rheumatic fever	55.10	16.47	53	11781	43058	63434130
Chronic sinusitis	48.28	16.47	30	11804	12813	63464375
Lip dry	47.94	16.47	32	11802	15438	63461750
Helicobacter infection	46.69	16.47	71	11763	92714	63384474
Deep vein thrombosis postoperative	46.42	16.47	28	11806	11341	63465847
Sciatica	45.38	16.47	43	11791	34281	63442907
Blood cholesterol increased	43.19	16.47	69	11765	93963	63383225
Fibromyalgia	42.54	16.47	63	11771	80357	63396831
Live birth	39.52	16.47	35	11799	25595	63451593
Autoimmune disorder	38.14	16.47	29	11805	17148	63460040
Paraesthesia oral	37.32	16.47	30	11804	19226	63457962
Hypercholesterolaemia	36.67	16.47	31	11803	21303	63455885
Prescribed overdose	36.30	16.47	38	11796	34115	63443073
Procedural pain	34.34	16.47	30	11804	21539	63455649
Injury	33.97	16.47	54	11780	73193	63403995
Mobility decreased	30.74	16.47	69	11765	121090	63356098
Road traffic accident	29.06	16.47	35	11799	36597	63440591
Rheumatoid factor positive	28.39	16.47	54	11780	84352	63392836
Sleep disorder due to general medical condition, insomnia type	27.74	16.47	41	11793	52176	63425012
Lower limb fracture	27.63	16.47	28	11806	24193	63452995
Infusion related reaction	27.28	16.47	104	11730	245417	63231771
Duodenal ulcer perforation	27.15	16.47	54	11780	87155	63390033
Intentional product use issue	26.16	16.47	67	11767	127825	63349363
Heart sounds	26.12	16.47	9	11825	987	63476201
Osteoarthritis	26.11	16.47	56	11778	95287	63381901
Prolonged expiration	25.28	16.47	9	11825	1087	63476101
Nail bed tenderness	24.72	16.47	7	11827	402	63476786
Toxicity to various agents	24.14	16.47	8	11826	247242	63229946
Septic arthritis staphylococcal	23.71	16.47	7	11827	466	63476722
Facet joint syndrome	23.71	16.47	19	11815	12119	63465069
Liver injury	21.95	16.47	40	11794	60480	63416708
Adverse event	21.22	16.47	42	11792	67517	63409671
Autonomic neuropathy	21.11	16.47	8	11826	1151	63476037
Swelling	20.89	16.47	104	11730	275274	63201914
Oedema	20.85	16.47	52	11782	97570	63379618
Lymphatic disorder	20.69	16.47	6	11828	375	63476813
Hip arthroplasty	20.55	16.47	34	11800	47612	63429576
Wheezing	20.50	16.47	51	11783	95544	63381644
Folliculitis	20.05	16.47	42	11792	70275	63406913
Psoriatic arthropathy	19.81	16.47	49	11785	91471	63385717
Vaginal flatulence	18.52	16.47	10	11824	3283	63473905
Drug interaction	18.24	16.47	10	11824	229121	63248067
General physical health deterioration	18.15	16.47	80	11754	201322	63275866
Irritable bowel syndrome	17.70	16.47	44	11790	82368	63394820
Liver disorder	17.62	16.47	34	11800	53653	63423535
Lupus vulgaris	17.61	16.47	12	11822	5982	63471206
Knee arthroplasty	17.39	16.47	34	11800	54172	63423016
Therapeutic product effect decreased	16.85	16.47	76	11758	193111	63284077
Therapy non-responder	16.80	16.47	41	11793	75860	63401328
Product use in unapproved indication	16.79	16.47	72	11762	179008	63298180
Adverse drug reaction	16.53	16.47	42	11792	79672	63397516
Depressive symptom	16.48	16.47	10	11824	4092	63473096

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Drug hypersensitivity	71.99	17.38	63	3634	80466	34872768
Staphylococcal skin infection	32.11	17.38	9	3688	885	34952349
Staphylococcal scalded skin syndrome	25.63	17.38	6	3691	287	34952947
Retinitis	23.75	17.38	6	3691	396	34952838
Renal injury	19.35	17.38	13	3684	11182	34942052
Mucosal inflammation	19.17	17.38	22	3675	38600	34914634
Vanishing bile duct syndrome	18.24	17.38	6	3691	1012	34952222
Multiple organ dysfunction syndrome	17.45	17.38	30	3667	76536	34876698

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Drug hypersensitivity	250.61	14.78	272	12487	298644	79432985
Toxic anterior segment syndrome	101.23	14.78	31	12728	2733	79728896
C-reactive protein	79.69	14.78	30	12729	4949	79726680
Swollen joint count increased	74.07	14.78	46	12713	22881	79708748
Rheumatic fever	67.24	14.78	47	12712	28478	79703151
Macular degeneration	64.70	14.78	33	12726	11263	79720366
Type 2 diabetes mellitus	52.93	14.78	55	12704	57067	79674562
Injury	50.29	14.78	62	12697	77434	79654195
Sciatica	50.18	14.78	42	12717	33180	79698449
Lip dry	47.44	14.78	30	12729	15388	79716241
Chronic sinusitis	46.85	14.78	28	12731	12998	79718631
Paraesthesia oral	46.54	14.78	33	12726	20438	79711191
Deep vein thrombosis postoperative	43.65	14.78	25	12734	10727	79720902
Rheumatoid factor positive	39.02	14.78	48	12711	59791	79671838
Procedural pain	38.67	14.78	31	12728	23053	79708576
Autoimmune disorder	38.28	14.78	27	12732	16585	79715044
Live birth	37.57	14.78	28	12731	18716	79712913
Duodenal ulcer perforation	35.17	14.78	48	12711	66163	79665466
Drug interaction	34.01	14.78	12	12747	415171	79316458
Road traffic accident	31.70	14.78	37	12722	43627	79688002
Glossodynia	31.39	14.78	58	12701	103279	79628350
Helicobacter infection	28.97	14.78	45	12714	69659	79661970
Sleep disorder due to general medical condition, insomnia type	28.49	14.78	35	12724	43521	79688108
Lower limb fracture	26.40	14.78	25	12734	23190	79708439
Hand deformity	26.29	14.78	54	12705	103865	79627764
Folliculitis	26.22	14.78	38	12721	55342	79676287
Nail bed tenderness	25.69	14.78	7	12752	407	79731222
Liver injury	24.16	14.78	37	12722	56577	79675052
Systemic lupus erythematosus	23.92	14.78	57	12702	121092	79610537
Heart sounds	23.73	14.78	8	12751	958	79730671
Pemphigus	23.16	14.78	50	12709	99532	79632097
Blood cholesterol increased	22.96	14.78	45	12714	83675	79647954
Psoriatic arthropathy	22.71	14.78	43	12716	77956	79653673
Vaginal flatulence	22.31	14.78	10	12749	2565	79729064
Lymphatic disorder	22.28	14.78	6	12753	334	79731295
Hip arthroplasty	22.21	14.78	28	12731	35728	79695901
Toxicity to various agents	22.03	14.78	21	12738	421519	79310110
Swelling	21.64	14.78	80	12679	216631	79514998
Prolonged expiration	21.58	14.78	8	12751	1263	79730366
Irritable bowel syndrome	21.55	14.78	37	12722	62204	79669425
Wound	21.17	14.78	53	12706	116126	79615503
Septic arthritis staphylococcal	21.05	14.78	7	12752	804	79730825
Prescribed overdose	20.93	14.78	28	12731	37855	79693774
Facet joint syndrome	20.70	14.78	16	12743	11286	79720343
Fibromyalgia	20.66	14.78	37	12722	64303	79667326
Staphylococcal skin infection	19.87	14.78	8	12751	1576	79730053
Anti-cyclic citrullinated peptide antibody positive	19.62	14.78	42	12717	83101	79648528
Wheezing	18.97	14.78	51	12708	116613	79615016
Liver disorder	18.75	14.78	38	12721	72379	79659250
Muscle injury	18.32	14.78	30	12729	48531	79683098
Impaired healing	18.12	14.78	42	12717	87613	79644016
Knee arthroplasty	18.08	14.78	28	12731	43220	79688409
Therapy non-responder	17.75	14.78	43	12716	92262	79639367
Ill-defined disorder	17.57	14.78	35	12724	65840	79665789
Infusion related reaction	17.42	14.78	78	12681	230159	79501470
Female genital tract fistula	16.83	14.78	11	12748	5964	79725665
Staphylococcal scalded skin syndrome	16.70	14.78	5	12754	408	79731221
Dyspepsia	16.17	14.78	46	12713	108641	79622988
Maternal exposure during pregnancy	15.86	14.78	53	12706	136485	79595144
Slow response to stimuli	15.53	14.78	7	12752	1818	79729811
Autonomic neuropathy	15.28	14.78	7	12752	1888	79729741
Retinitis	14.95	14.78	10	12749	5633	79725996
Dry mouth	14.83	14.78	39	12720	87980	79643649

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A01AB08	ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS Antiinfectives and antiseptics for local oral treatment
ATC	A07AA01	ALIMENTARY TRACT AND METABOLISM ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS INTESTINAL ANTIINFECTIVES Antibiotics
ATC	A07AA51	ALIMENTARY TRACT AND METABOLISM ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS INTESTINAL ANTIINFECTIVES Antibiotics
ATC	B05CA09	BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS IRRIGATING SOLUTIONS Antiinfectives
ATC	D06AX04	DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ANTIBIOTICS FOR TOPICAL USE Other antibiotics for topical use
ATC	J01GB05	ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE AMINOGLYCOSIDE ANTIBACTERIALS Other aminoglycosides
ATC	R02AB01	RESPIRATORY SYSTEM THROAT PREPARATIONS THROAT PREPARATIONS Antibiotics
ATC	S01AA03	SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Antibiotics
ATC	S02AA07	SENSORY ORGANS OTOLOGICALS ANTIINFECTIVES Antiinfectives
ATC	S03AA01	SENSORY ORGANS OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS ANTIINFECTIVES Antiinfectives
FDA CS	M0000946	Aminoglycosides
FDA EPC	N0000175477	Aminoglycoside Antibacterial
MeSH PA	D000900	Anti-Bacterial Agents
MeSH PA	D000890	Anti-Infective Agents
MeSH PA	D004791	Enzyme Inhibitors
MeSH PA	D011500	Protein Synthesis Inhibitors
CHEBI has role	CHEBI:36047	antibacterial drugs
CHEBI has role	CHEBI:50904	alergeno

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Otitis externa	indication	3135009
Keratitis	indication	5888003	DOID:4677
Hepatic encephalopathy	indication	13920009	DOID:13413
Urinary tract infectious disease	indication	68566005
Blepharoconjunctivitis	indication	68659002	DOID:2456
Hepatic coma	indication	72836002	DOID:12550
Corneal abrasion	indication	85848002
Uveitis	indication	128473001	DOID:13141
Infective blepharitis	indication	312219000
Bacterial keratitis	indication	314557000
Minor Skin Wound Pain	indication
Superficial Ocular Infection	indication
Mastoidectomy Cavity Infections	indication
Preoperative Bowel Preparation	indication
Minor Bacterial Skin Infections	indication
Chronic purulent otitis media	off-label use	38394007	DOID:14247
Bacterial conjunctivitis	off-label use	128350005	DOID:9700
Ocular hypertension	contraindication	4210003	DOID:9282
Hypocalcemia	contraindication	5291005
Herpes simplex keratitis	contraindication	9389005
Herpes zoster auricularis	contraindication	21954000	DOID:9210
Hypovolemia	contraindication	28560003
Herpes simplex dendritic keratitis	contraindication	29943008
Fungal infection of eye	contraindication	31194008
Parkinsonism	contraindication	32798002
Bullous myringitis	contraindication	33528003	DOID:13791
Dehydration	contraindication	34095006
Severe myopia	contraindication	34187009
Tuberculosis of eye	contraindication	49107007
Neuromuscular block, function	contraindication	55394004
Perforation of tympanic membrane	contraindication	60442001
Tinnitus	contraindication	60862001
Diabetes mellitus	contraindication	73211009	DOID:9351
Third degree burn injury	contraindication	80247002
Open-angle glaucoma	contraindication	84494001	DOID:1067
Krukenberg spindle	contraindication	85430004
Ulceration of intestine	contraindication	85942002
Herpes simplex	contraindication	88594005	DOID:8566
Kidney disease	contraindication	90708001	DOID:557
Myasthenia gravis	contraindication	91637004	DOID:437
Procedure on urinary system	contraindication	118677009
Open wound	contraindication	125643001
Gastrointestinal obstruction	contraindication	126765001
Eye infection	contraindication	128351009
Hearing disorder	contraindication	128540005
Bacterial infection of eye	contraindication	128984004
Tuberculosis of ear	contraindication	186269001
Toxic nephropathy	contraindication	236514003
Telangiectasia disorder	contraindication	247479008
Rupture of bladder	contraindication	251925007
Injury of eye region	contraindication	282752000
Pregnancy, function	contraindication	289908002
Viral eye infection	contraindication	312132001
Viral ear infection	contraindication	312137007
Fungal ear infection	contraindication	312148000
Adrenal cortical hypofunction	contraindication	386584007	DOID:10493
Vaccinia keratitis	contraindication	397552005
Vertigo	contraindication	399153001
Atrophoderma	contraindication	399979006
Peripheral vascular disease	contraindication	400047006
Infant Botulism	contraindication
Auditory Neurotoxicity	contraindication
Disorder of the 8th Cranial Nerve	contraindication

🐶 Veterinary Drug Use

Species	Use	Relation
Cats	Bacterial infections	Indication
Cats	Wound infections	Indication
Cats	Superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye	Indication
Cattle	Colibacillosis caused by Escherichia coli	Indication
Dogs	Bacterial infections	Indication
Dogs	Bacterial diarrhea	Indication
Dogs	Wound infections	Indication
Dogs	Superficial ocular bacterial infections limited to the conjunctival or the anterior segment of the eye	Indication
Goats	Colibacillosis caused by Escherichia coli	Indication
Horses	Ear and skin conditions caused by organisms	Indication
Horses	Ear and skin conditions caused by allergy	Indication
Horses	Superficial dressing applied to minor cuts	Indication
Horses	Superficial dressing applied to wounds	Indication
Horses	Superficial dressing applied to lacerations	Indication
Horses	Superficial dressing applied to abrasions	Indication
Horses	Superficial dressing for post-surgical application	Indication
Sheep	Colibacillosis caused by Escherichia coli	Indication
Swine	Colibacillosis caused by Escherichia coli	Indication
Turkeys	Control of mortality associated with Escherichia coli	Indication

🐶 Veterinary products

Product	Applicant	Ingredients
Neo-Cortef with Tetracaine	Zoetis Inc.	3
Neomix 325 Soluble Powder, Neomix AG 325 Soluble Powder	Zoetis Inc.	1
Hydeltrone Ointment	Boehringer lngelheim Animal Health USA Inc.	2
Neo-Delta-Cortef with Tetracaine Ointment	Zoetis Inc.	3
Biosol Sterile Solution, Biosol Sterile Solution 50 mg	Zoetis Inc.	1
Panolog Ointment	Zoetis Inc.	4
Jenomycin Tablets	Intervet Inc.	2
Neo-synalar Cream	Bausch Health US LLC	2
Neo-Predef with Tetracaine Powder	Zoetis Inc.	3
Neo-Predef with Tetracaine Top. Ointment, Tritop Topical Ointment	Zoetis Inc.	3
Neo-Darbazine Spansule Capsule No.1, Neo-Darbazine Spansule Capsule No.3	Zoetis Inc.	3
Neo Predef Sterile Ointment	Zoetis Inc.	2
Anaprime Ophthalmic Solution	Zoetis Inc.	3
Kymar Ointment Improved	Intervet Inc.	4
Tresaderm Dermatologic Solution	Boehringer lngelheim Animal Health USA Inc.	3
Anaprime Opthakote Ophthalmic	Zoetis Inc.	3
Optiprime Opthakote Ophthalmic Solution	Zoetis Inc.	2
Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment, Vetropolycin HC Ophthalmic Ointment	Dechra, Ltd.	4
Bac-Neo-Poly Ophthalmic Ointment, Vetropolycin Ophthalmic Ointment	Dechra, Ltd.	3
Mycitracin Sterile Ophthalmic Ointment	Zoetis Inc.	3
Forte Topical Ointment	Zoetis Inc.	4
Cortisporin Veterinary Ophthalmic Ointment	Intervet Inc.	4
Neosporin Ophthalmic Ointment	Intervet Inc.	3
Neo-Delta Cortef Sterile Solution	Zoetis Inc.	2
Neo-Cortef Sterile Ointment	Zoetis Inc.	2
Neo-Terramycin 100/100, Neo-Terramycin 100/100D, Neo-Terramycin 50/50, Neo-Terramycin 50/50D	Phibro Animal Health Corp.	2
Panolog Cream	Zoetis Inc.	4
Neo-Oxy 100/100 MR, Neo-Oxy 50/50	Pharmgate Inc.	2
DERMA-VET Ointment	Med-Pharmex Inc.	4
Animax Ointment	Fougera Pharmaceuticals Inc.	4
Derma 4 Ointment	Zoetis Inc.	4
Neomix Ag 325 Medicated Premix, Neomix 325 Medicated Premix	Zoetis Inc.	1
Derm-Otic Ointment	Zoetis Inc.	4
Neomycin Sulfate	Zoetis Inc.	1
NeoMed Soluble Powder	Bimeda Animal Health Limited	1
Biosol Liquid	Zoetis Inc.	1
Neomycin Oral Solution	Huvepharma EOOD	1
Neo-Sol 50	Huvepharma EOOD	1
Neo 200 Oral Solution	Huvepharma EOOD	1
Neosol Soluble Powder	Med-Pharmex Inc.	1
Derma-Vet Cream	Med-Pharmex Inc.	4
Neosol-Oral	Med-Pharmex Inc.	1
Animax Cream	Fougera Pharmaceuticals Inc.	4
Neomycin Sulfate 325	Sparhawk Laboratories Inc.	1
Neomycin Liquid	Sparhawk Laboratories Inc.	1
Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment	Akorn Animal Health Inc.	3
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution	Dechra Veterinary Products LLC	3

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Bioact source
Transient receptor potential cation channel subfamily V member 1	Ion channel	Q8NER1	TRPV1_HUMAN		IC50	6.40	CHEMBL
Lecithin retinol acyltransferase	Enzyme	O95237	LRAT_HUMAN		IC50	4.83	CHEMBL
Menin	Unclassified	O00255	MEN1_HUMAN		Kd	4.81	CHEMBL
Lethal factor	Enzyme		LEF_BACAN		Ki	6.30	CHEMBL
Extracellular calcium-sensing receptor	GPCR		CASR_RAT	AGONIST	Kd	4	IUPHAR

External reference:

ID	Source
4018765	VUID
N0000178941	NUI
D01618	KEGG_DRUG
4017501	VANDF
4017991	VANDF
4018765	VANDF
C0027603	UMLSCUI
CHEBI:7507	CHEBI
NMY	PDB_CHEM_ID
CHEMBL3989751	ChEMBL_ID
CHEMBL3989769	ChEMBL_ID
D009355	MESH_DESCRIPTOR_UI
DB00994	DRUGBANK_ID
709	IUPHAR_LIGAND_ID
232	INN_ID
I16QD7X297	UNII
8378	PUBCHEM_CID
7299	RXNORM
2184	MMSL
35157	MMSL
5163	MMSL
5164	MMSL
d00312	MMSL
002775	NDDF
002777	NDDF
373528008	SNOMEDCT_US
70961008	SNOMEDCT_US
73093001	SNOMEDCT_US
96026000	SNOMEDCT_US
CHEMBL3989533	ChEMBL_ID
1404-04-2	SECONDARY_CAS_RN
55298-68-5	SECONDARY_CAS_RN

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
MAXITROL	HUMAN PRESCRIPTION DRUG LABEL	3	0065-0631	OINTMENT	3.50 mg	OPHTHALMIC	NDA	18 sections
MAXITROL	HUMAN PRESCRIPTION DRUG LABEL	3	0078-0771	OINTMENT	3.50 mg	OPHTHALMIC	NDA	18 sections
MAXITROL	HUMAN PRESCRIPTION DRUG LABEL	3	0078-0771	OINTMENT	3.50 mg	OPHTHALMIC	NDA	18 sections
MAXITROL	HUMAN PRESCRIPTION DRUG LABEL	3	0078-0771	OINTMENT	3.50 mg	OPHTHALMIC	NDA	18 sections
Maxitrol	HUMAN PRESCRIPTION DRUG LABEL	3	0078-0792	SUSPENSION	3.50 mg	OPHTHALMIC	NDA	18 sections
Neomycin Sulfate	HUMAN PRESCRIPTION DRUG LABEL	1	0093-1177	TABLET	500 mg	ORAL	ANDA	22 sections
Neomycin Sulfate	HUMAN PRESCRIPTION DRUG LABEL	1	0093-1177	TABLET	500 mg	ORAL	ANDA	22 sections
Neomycin Sulfate	HUMAN PRESCRIPTION DRUG LABEL	1	0093-1177	TABLET	500 mg	ORAL	ANDA	22 sections
Good Sense First Aid Antibiotic	HUMAN OTC DRUG LABEL	3	0113-0084	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Good Sense Triple Antibioticand Pain Relief	HUMAN OTC DRUG LABEL	4	0113-0679	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
basic care first aid antibiotic	HUMAN OTC DRUG LABEL	3	0113-0701	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
good sense triple antibiotic	HUMAN OTC DRUG LABEL	4	0113-1140	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Basic Care First Aid Antibiotic Plus Pain Relief	HUMAN OTC DRUG LABEL	4	0113-7679	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
AntibioticMaximum Strength	HUMAN OTC DRUG LABEL	3	0363-0018	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
AntibioticMaximum Strength	HUMAN OTC DRUG LABEL	3	0363-0018	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Triple Antibiotic with Pain ReliefMaximum Strength	HUMAN OTC DRUG LABEL	4	0363-0123	OINTMENT	3.50 mg	TOPICAL	OTC MONOGRAPH FINAL	13 sections
Triple Antibiotic	HUMAN OTC DRUG LABEL	3	0363-0179	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Triple Antibiotic	HUMAN OTC DRUG LABEL	3	0363-0179	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Triple Antibiotic	HUMAN OTC DRUG LABEL	3	0363-0179	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
triple antibiotic	HUMAN OTC DRUG LABEL	3	0363-0539	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	15 sections
triple antibiotic	HUMAN OTC DRUG LABEL	3	0363-0539	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	15 sections
triple antibiotic	HUMAN OTC DRUG LABEL	3	0363-0539	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	15 sections
First Aid Antibiotic	HUMAN OTC DRUG LABEL	4	0363-0841	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
First Aid Antibiotic	HUMAN OTC DRUG LABEL	4	0363-0841	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Walgreens Triple Antibiotic	HUMAN OTC DRUG LABEL	3	0363-2016	OINTMENT	3.50 mg	TOPICAL	OTC MONOGRAPH FINAL	14 sections
Walgreens Kids Multi-Antibiotic with Pain Relief Cream	HUMAN OTC DRUG LABEL	3	0363-2122	CREAM	3.50 mg	TOPICAL	OTC monograph not final	11 sections
Walgreens Multi-Antibiotic with Pain Relief Cream	HUMAN OTC DRUG LABEL	3	0363-2123	CREAM	3.50 mg	TOPICAL	OTC monograph not final	9 sections
Triple Antibiotic	HUMAN OTC DRUG LABEL	4	0363-2900	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Triple Antibiotic	HUMAN OTC DRUG LABEL	4	0363-2900	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	13 sections
Walgreens Maximum Strength Triple Antibiotic With Pain Relief	HUMAN OTC DRUG LABEL	4	0363-7872	OINTMENT	3.50 mg	TOPICAL	OTC monograph final	11 sections